|
|
||||||||
Department of Pathology and Committee on Immunology, The University of Chicago, Chicago, IL 60637
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
B-induding kinase, TNFR-associated factor 6 (TRAF6), v-rel reticuloendotheliosis viral oncogene homolog B (Rel B), NF-
B2, and chemokine (c-c motif) receptor 7 (6, 7, 8, 9, 10, 11), although their roles have not been directly demonstrated. Clear definition of their functions in the organ-specific central tolerance will not only help to uncover the complex regulation of organ-specific autoimmune diseases, but also provide new targets for future diagnostic and therapeutic intervention of organ-specific autoimmune diseases. LTβR-deficient mice harbor an autoimmune phenotype characterized by increased lymphocytic infiltration of peripheral organs and humoral autoreactivity (8, 12, 13). LTβR was recently proposed to be involved in the control of negative selection of organ-specific autoreactive thymocytes in both Aire-dependent and independent pathways (8, 12, 13). However, this hypothesis has not been formally tested and little is known about the underlying mechanisms. This issue becomes even more intriguing given the controversial data available at present. Although one study showed that LTβR signaling may be directly involved in the regulation of Aire expression (12), another study suggested an indirect mechanism via the development and differentiation of thymic medulla epithelial cells (13). A third study demonstrated apparently normal Aire expression in Lta–/– mice, in which the ligand for LTβR is deficient, raising the possibility that increased peripheral tissue infiltration is not related to the defect in Aire-dependent negative selection (11). Whether and how LTβR is involved in organ-specific thymic negative selection remains to be determined. In this study, we clarify and confirm the essential role of LTβR in the negative selection of organ-specific autoreactive T cells. Our data further suggests that LTβR controls this process by regulating medullary chemokine expression for cortex-to-medulla thymocyte migration.
| Materials and Methods |
|---|
|
|
|---|
Ltbr–/– mice have been previously described (8). Aire–/– mice were generated with a mixed genetic background as described (14) and back-crossed to C57BL/6 for at least six generations in our laboratory. OT-I TCR transgenic mice on C57BL/6 background were purchased from The Jackson Laboratory. RIP-mOVA transgenic mice on C57BL/6 background were obtained from Dr. W. R. Heath, Division of Immunology (The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia). The plt mice were obtained from J. G. Cyster (University of California, San Francisco, CA). Animal care and experiments were performed in accordance with the institution and National Institutes of Health guidelines and approved by the animal use committee at the University of Chicago.
Bone marrow reconstitution and splenocytes adoptive transfer
Mice were lethally irradiated with 1000 rads and adoptively transferred i.v. with 3 x 106 bone marrow cells the next day. Bactrim was added to the drinking water for 3 wk following irradiation. Thymocytes and splenocytes were analyzed 8–9 wk after transfer and in some cases 12 wk after transfer. For splenocyte adoptive transfer experiments, splenocytes from bone marrow chimeric mice were recovered when mice were sacrificed and 20 x 106 splenocytes were transferred to sublethally (400 rad) irradiated rat insulin 2 promoter (RIP)-mOVA mice. Bactrim was applied for 3 wk following irradiation. Mice were sacrificed for pancreas histopathology analysis 4 wk after splenocytes adoptive transfer.
Immunofluoresence staining
Six-micron frozen sections were fixed in acetone at 4°C for 10 min, rehydrated in PBS/saponin (0.1%), and blocked with goat serum (5%) or BSA (1%) in PBS at room temperature for 1 h. Primary Abs include anti-Ep-CAM (G8.8; BD Biosciences), UEA-1-bio (Sigma-Aldrich), anti-CD8 (53-6.7; BD Biosciences), anti-CD11c (N418; BD Biosciences), anti-CD19 (1D3; BD Biosciences), anti-F4/80 (BM8; eBiosciences), and anti-insulin (abCAM). Tissue sections were incubated with primary Abs at 4°C overnight and visualized with appropriate fluorescence reagents.
Thymi morphometrics analysis
Mice were sublethally irradiated with 400 rad. Thymi sectioning and immunocluoresence staining were performed as described above. ImageJ 1.34 (National Institutes of Health) software was used to calculate the cortex and medulla areas. The medulla was identified as a continuous area with UEA1 positive staining. Because only rare CD4CD8 DP thymocytes were present in sublethally irradiated mice, CD8 SP thymocytes distribution and quantity were visualized by FITC-conjugated anti-CD8 Ab (53-6.7; BD Biosciences). CD8 SP cells in medulla/cortex were counted and their distribution density was calculated.
Flow cytometry analysis
Single cell suspensions from the thymus and spleen were stained with anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-CD24 (30-F1), anti-CD69 (H1.2F3) mAbs (BD Biosciences), and OVA Tetramer H-2 Kb SIINFEKL-PE (Beckman Coulter) in PBS containing 0.2% BSA and 0.09% sodium azide. Before staining, the cells were preincubated with anti-Fc
III/II receptor (2.4G2; BD Biosciences). Foxp3 intracellular staining was conducted using Mouse Regulatory T Cell Staining Kit following the manufacturers instructions (eBioscience). Stained cells were analyzed on FACSCanto (BD Biosciences). mTECs sorting was performed as previously described (6). The purity was routinely higher than 90%.
Real-time PCR
Real-time PCR was conducted on cDNA prepared from DNase I-treated RNA extracted from whole thymus or purified mTECs from 4- to 6-wk-old mice. The primers and probes used are as follows. For Insulin2: Forward, 5'-CTTCAGACCTTGGCGTTGGA-3', Reverse, 5'-ATGCTGGTGCAGCACTGATC-3', Probe, 5'-FAM-CCCGGCAGAAGCGTGGCATT-TAMRA-3. For mOVA: Forward, 5'-ATCTCAAGCTGTCCATGCAG-3', Reverse, 5'-TGCGATGTGCTTGATACAGA-3', Probe, 5'-FAM-CGCTTGCAGCATCCACTCCA-TAMRA-3'. For secondary lymphoid tissue chemokine (SLC): Forward, 5'-AGACTCAGGAGCCCAAAGCA-3', Reverse, 5'-GTTGAAGCAGGGCAAGGGT-3', Probe, 5'-FAM-CCACCTCATGCTGGCCTCCGTC-TAMRA-3'. For EBV-induced molecule 1 ligand chemokine (ELC): Forward, 5'-ATGCGGAAGACTGCTGCCT-3', Reverse, 5'-GGCTTTCACGATGTTCCCAG-3', Probe, 5'-FAM-TCTGTGACCCAGCGCCCCATC-TAMRA-3'. For GAPDH: Forward, 5'-TTCACCACCATGGAGAAGGC-3', Reverse, 5'-GGCATGGACTGTGGTCATGA-3' Probe, 5'-FAM-TGCATCCTGCACCACCAACTGCTTAG-TAMRA-3'. Reactions were run on the ABI/Prism 7300 (Applied Biosystems), in a final volume of 25 µl with 900 nM of the forward and reverse primers and 200 nM of the probe using 2x Taqman Master Mix (Applied Biosystems) containing AmpliTaq Gold polymerase. Cycling conditions were a single denaturing step at 95°C for 15 min followed by 45 cycles of 94°C for 15 s and 60°C for 1 min. Analysis of Ins2, mOVA, SLC, ELC, and Gapdh gene expression were performed with a standard curve, and then normalized to sample Gapdh. The standard curves had R2 values >0.99.
Histopathology
Tissues for histological examination were fixed in 10% buffered formalin and embedded in paraffin. Four- to five-micron sections were obtained from the paraffin blocks and stained using H&E stain methods. All sections were then examined by a pathologist in a blinded fashion.
| Results |
|---|
|
|
|---|
In mice with a native polyclonal TCR repertoire, the fate of autoreactive thymocytes can be difficult to trace. We thus took advantage of the OT-I/RIP-mOVA transgenic system to uncover the role of LTβR in regulating negative selection. In this system, mOVA expression is driven by RIP, mimicking an organ-specific self-Ag. OT-I thymocytes are routinely negatively selected in the thymi of RIP-mOVA transgenic mice (4, 15, 16). To determine whether LTβR controls the negative selection of organ-specific autoreactive thymocytes, we made bone marrow chimera with OT-I+ donor bone marrow transplanted into either RIP-mOVA+ or RIP-mOVA+Ltbr–/– hosts. The development of OT-I+ T cells was analyzed 8–9 wks later by flow cytometric staining with OT-I clonotype-specific tetramer and thymocyte maturation markers.
Following OT-I bone marrow transplantation, thymocytes in recipients wild type (WT) (Ltbr+/+) and Ltbr–/– developed normally and CD8+OT-I+ T cells were predominantly positively selected (Fig. 1A). In RIP-mOVA/Ltbr+/+ recipients of OT-I bone marrow transplantation, the CD8+ single positive (SP) population in the thymus was significantly reduced by 3-fold. Within this reduced CD8+ SP population, the percentage of OT-I+ clonotypic cells was even more severely decreased from around 77% in WT to 21% in RIP-mOVA+ mice (Fig. 1, A and B). This led to, in absolute terms, about a 10-fold reduction of CD8+ OT-I clonotypic T cells in the presence of thymic mOVA expression in the RIP-mOVA recipients, suggesting an efficient thymic negative selective process (Fig. 1, A and B and Refs. 4, 16). The further addition of LTβR deficiency (RIP-mOVA/Ltbr–/–), however, rescued 2.5-fold of OT-I+ clonotypic cells (Fig. 1, A and B). When CD24 was added as a marker to further define the postselection, fully mature OT-I cells, few CD24– OT-I cells were seen in the RIP-mOVA+Ltbr+/+ recipients. In contrast, analysis of RIP-mOVA+Ltbr–/– thymi revealed a 40-fold increase in postselection mature OT-I+ population (CD24 negative), apparently rescued by LTβR deficiency (Fig. 1, A and B). Dramatic rescue of mature OT-I+ cells by LTβR deficiency was also seen when CD69 was used as a maturation marker (Fig. 1, A and B). These data thus strongly suggested an important role of LTβR in the thymic negative selection of OT-I+ thymocytes.
|
Development of CD4+Foxp3+ Treg is another important mechanism in the maintenance of central tolerance. To determine whether Treg development was impaired in the absence of LTβR, thymocytes from WT and Ltbr–/– mice were first intracellular stained with Foxp3 and analyzed by flow cytometry. No differences in the percentage or the absolute number of CD4+Foxp3+ cells were found between WT and Ltbr–/– mice (Fig. 2, A and B). To confirm this finding, Foxp3 expression level was also analyzed by quantitative real-time PCR and found unchanged in the thymi of Ltbr–/– mice (Fig. 2C). The expression level of Foxp3 also found no difference by comparing the mean fluorescence intensity between WT and Ltbr–/– Treg cells (data not shown), indicating a normal Treg function (17). Therefore, it appears that LTβR deficiency does not significantly influence the development of conventional CD4+Foxp3+ Treg cells. Whether other regulatory T cell populations, e.g., Th1, Tr1, or even CD8+ regulatory T cells (18), are generated during thymic development and influenced by LTβR remains to be determined.
|
To further dissect how LTβR deficiency impinges on thymic negative selection, we first analyzed the ectopic thymic expression level of the neo-self Ag, as this is a crucial factor for thymocytes selection (4, 19, 20). Thymic expression levels of the neo-Ag mOVA were determined by quantitative real-time PCR. LTβR was shown to be necessary for thymic Aire expression, and Aire shown necessary for thymic insulin 2 expression. Given that the RIP-mOVA gene is driven by insulin 2 promoter, we expected reduced thymic mOVA expression in the absence of LTβR signaling. We found rather that expression levels of mOVA in the thymi of RIP-mOVA+Ltbr+/+ and RIP-mOVA+Ltbr–/– were equivalent (Fig. 3A). This is consistent with a recent study demonstrating that mOVA thymic expression is not reduced on Aire–/– background (4, 19, 20). However, the native insulin 2 expression was indeed reduced in RIP-mOVA+Ltbr–/– thymi (Fig. 3A). The RIP promoters independence from Aire control may be due to its deficiency in necessary cis-elements, either due to species specific differences or loss during cloning. Chromosomal integration-site effect on the RIP-driven expression of transgenes is a further possible explanation (4, 21).
|
To further determine whether the reduced expression of medullary chemokines will disturb the migration of thymocytes into the medulla, we adopted the following approach (29). Mice were sublethally (400 rad) irradiated to deplete the majority of their immature double positive (DP) thymocytes. The thymic localization of SP thymocytes of WT, Ltbr–/–, and plt were determined by immunofluoresence staining. Sublethal irradiation has been shown to induce apoptosis of immature cortical DP thymocytes, while sparing mature medullary SP thymocytes (31). In fact, when immunofluoresence staining was performed to check CD4/CD8 expression, only rare DP cells were found in the irradiated thymi (data not shown). Because CD8 staining was better visualized than that of CD4, we compared CD8 SP intrathymic localization in the thymi from different genotypes. In sublethally irradiated WT mice, most CD8 SP cells were found to be located in the medulla (Fig. 3, D and E). plt mice have significantly reduced SLC expression and no ELC expression (32, 33) and significant arrest of cortex-to-medulla migration of SP cells was reported in plt mice due to lack of SLC/ELC thymic expression (29). Similar to that in plt thymi, in the medulla of Ltbr–/– thymi, the CD8SP cell numbers were found also significantly reduced compared with that in WT thymi (Fig. 3, D and E). As a consequence, the CD8SP cells in the cortex of both Ltbr–/– and plt thymi are significantly increased (Fig. 3, D and E). Thus, LTβR deficiency not only results in down-regulation of thymic SLC/ELC expression, but also impairs the cortex-to-medulla migration of CD8SP thymocytes.
Impaired thymic negative selection leads to peri-insulitis
To characterize the impact of this defect in negative selection on the peripheral T cell repertoire, splenocytes from bone marrow chimeras were first analyzed by flow cytometric staining with OT-I specific tetramer. We found a significantly increased peripheral population of OT-I+ T cells in RIP-mOVA+Ltbr–/– recipients relative to RIP-mOVA+Ltbr+/+ recipients (Fig. 4, A and B), suggesting that this thymic defect may have real peripheral consequences.
|
RIP-mOVA+Ltbr+/+ and OT-I
RIP-mOVA+Ltbr–/– bone marrow chimeric mice were secondarily adoptively transferred to sublethally irradiated RIP-mOVA+ mice to test whether they lead to autoimmune response targeting to the pancreas. Four weeks after secondary transfer, mice were sacrificed and pancreata were checked for lymphocyte infiltration by histostaining. Although there was only occasional peri-islet infiltration noted in the RIP-mOVA+ recipients of OT-I
RIP-mOVA+Ltbr+/+ splenocytes, significant infiltration was seen in >75% of the islets analyzed in RIP-mOVA+ recipients OT-I
RIP-mOVA+Ltbr–/– chimeric mice (Fig. 4C). Immunofluoresence staining revealed that the infiltrates were composed of CD8 T cells, B cells, macrophages, and dendritic cells (data not shown), a similar composition to previously reported insulitis (34). Thus, not only do more OT-I+ cells escape thymic negative selection in the absence of LTβR, but also they carry a functional impact, leading to infiltration of the islets and development of peri-insulitis. Thymic chemotactic defect alone is sufficient to impair the negative selection
To evaluate whether the dysregulation of chemokines in the Ltbr–/– thymus are in themselves sufficient to produce the witnessed defects in thymic negative selection, we used RIP-mOVA+/plt mice as OT-I BM transfer recipients. plt thymi harbor an isolated defect in the expression of thymic SLC/ELC and were earlier shown to have impaired medullary migration of SP thymocytes. Similarly to RIP-mOVA+Ltbr–/– recipients, we found significantly increased populations of clonotypic OT-I+ T cells in RIP-mOVA+/plt recipients (Fig. 5, A and B). This result confirms regulation of thymocyte chemotaxis as a significant component in the schema of LTβR control of negative selection. However, our current data do not exclude other mechanisms used by LTβR for control of thymic negative selection (see Discussion).
|
| Discussion |
|---|
|
|
|---|
B-induding kinase, TRAF6, RelB, NF-
B2, and CCR7 (6, 7, 8, 9, 10, 11, 12). In mice genetically deficient in these factors, there is clear lymphocytic infiltration targeting multiple peripheral organs. However, the mechanism of their contribution to organ-specific central tolerance has not been directly demonstrated. In this study, by taking advantage of OT-I and RIP-mOVA transgenic system, we present direct evidence that LTβR is critical in the thymic negative selection of organ-specific T cells. We further revealed that LTβR controls thymic expression of SLC and ELC, key chemokines controlling the migration of developing thymocytes from the thymic cortex to the medulla (9, 29, 30, 35). Dysregulation of the CCR7-CCR7L (SLC/ELC) axis has been proposed to be associated with impaired central tolerance (9), but it is not clear whether negative selection, Treg generation, or anergy is affected. We have now provided the first direct evidence that SLC/ELC, dependent on LTβR signaling, is required for proper thymic negative selection. Because it is difficult to trace the fate of organ-specific autoreactive T cells in a native polyclonal repertoire, the OT-I/RIP-mOVA transgenic system was used in this study. Although the mOVA gene expression is under control of RIP in these mice and is supposed to mimic the regulation of insulin 2 expression, a recent study has shown clear evidence that significant differences remain (4). In our system, mice deficient in LTβR fail to demonstrate reductions in thymic RIP-mOVA expression, even while native thymic Ins2 expression is reduced (4). Although RIP-mOVA is an imperfect mimic of native insulin expression, the OT-I—RIP-mOVA system was valuable in dissecting other mechanisms essential for negative selection. As presented earlier, LTβR also controls several key medullary chemokines required for proper thymocyte migration, in a manner similar to what has been found in Aire–/– thymi (4). Given the reduced Aire expression in Ltbr–/– thymi, it therefore becomes an interesting question of whether these defects in Ltbr–/– thymi are dependent on Aire function. To address this question, we compared several genes regulated by Aire and/or LTβR. SLC and ELC are two key chemokines known to be involved in the regulation of thymocyte migration into the thymic medulla. Although both are significantly reduced in Ltbr–/– thymi, neither of them was reduced in Aire–/– thymi (data not shown). This difference suggests that, although both LTβR and Aire are involved in the negative selection process, they may have both overlapping and distinct mechanisms.
Although our data suggest that reduced expression of medullary chemokine (SLC and ELC) expression in Ltbr–/– thymus is in itself sufficient to disturb thymic negative selection, other mechanisms may also be involved. This is indicated by the partial rescue of OT-I T cells in RIP-mOVA+plt mice relative to RIP-mOVA+Ltbr–/– mice. Boehm et al. (13), for example, reported disorganized thymus medulla in Ltbr–/– mice. Other potential mechanisms of LTβR control of thymic negative selection might reside in function of mTECs or other thymic APCs. Their relative contributions need to be determined in further studies.
Dendritic cells (DC), upon activation, also express CCR7 and become responsive to SLC/ELC (36). Their migration and localization were also found defective in the secondary lymphoid organs of plt mice (37). Because DCs have been shown to mediate thymic negative selection in the OT-I/RIP-mOVA system (16), the impaired negative selection in our Ltbr–/– mice could be also due to improper DCs localization in the thymus. However, tissue staining failed to show any differences in thymic localization of DCs among WT, Ltbr–/–, and plt mice. Most DCs were properly located into the medulla region (data not shown and Ref. 9). Thus, thymic migration and localization of DCs may not rely on the CCR7-CCR7L chemotaxis and is unlikely to be a major contributor to impaired thymic negative selection in our Ltbr–/– mice. Whether our Ltbr–/– DCs have an intrinsic functional defect that contributes to the Ltbr–/– phenotype, as was suggested recently (38), remains an interesting question for future study.
Although significantly more OT-I T cells escaped thymic negative in the RIP-mOVA+Ltbr–/– than in RIP-mOVA+Ltbr+/+ hosts, these autoreactive T cells were held in check by the absence of lymph nodes necessary for priming in their Ltbr–/– hosts. Florid autoimmunity developed upon secondary transfer, when this restriction was relieved. The absence of hyperglycemia in these mice, which could be due to the limited number of autoreactive T cells transferred. This is consistent with previous findings that transfer of small numbers of OT-I T cells (< 1 x 106, which is the case in our experiments) into RIP-mOVA+ mice fails to induce diabetes (34).
In conclusion, we have now clearly demonstrated that LTβR is required for the thymic negative selection of organ-specific T cells. Medullary chemokine regulation has been revealed to be an important pathway used by LTβR to control organ-specific negative selection. Our study defines the novel role of LTβR in establishing organ-specific central tolerance, helps to unravel the complex regulation of organ-specific autoimmunity, and provides new targets for future diagnostic and therapeutic intervention of organ-specific autoimmune diseases.
| Note added in proof. |
|---|
|
|
|---|
| Acknowledgment |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This research was supported by Grants from National Institutes of Health AI062026 and DK58897 (to Y.X.F.). ![]()
2 Address correspondence and reprint requests to Dr. Yang-Xin Fu, Department of Pathology and Committee on Immunology, The University of Chicago, 5841 S. Maryland, Room J541, MC3083, Chicago, IL 60637. E-mail address: yfu{at}uchicago.edu ![]()
3 Abbreviations used in this paper used in this manuscript: Treg, regulatory T cell; TRA, tissue-restricted self-Ag; SLC, secondary lymphoid tissue chemokine; ELC, EBV-induced molecule 1 ligand chemokine; mTEC, medullary thymic epithelial cell; Aire, autoimmune regulator; LTβR, lymphotoxin β receptor; RIP, rat insulin 2 promoter; WT, wild type; DC, dendritic cell; TRAF6, TNF receptor-associated factor 6; RelB, v-rel reticuloendotheliosis viral oncogenehomolog B; CCR7, chemokine (C-C motif) receptor 7; SP, single positive; DP, double positive. ![]()
Received for publication June 14, 2007. Accepted for publication October 3, 2007.
| References |
|---|
|
|
|---|
B2 is required for the establishment of central tolerance through an Aire-dependent pathway. J. Clin. Invest. 116: 2964-2971. [Medline]
B2 is required for the control of autoimmunity by regulating the development of medullary thymic epithelial cells. J. Biol. Chem. 281: 38617-38624.
B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol. 172: 2067-2075.
B/Rel family. Cell 80: 331-340. [Medline]
/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189: 403-412.
β on antigen-specific T cells is required for DC function. J. Exp. Med. 204: 1071-1081. This article has been cited by other articles:
![]() |
T. Nitta, S. Nitta, Y. Lei, M. Lipp, and Y. Takahama CCR7-mediated migration of developing thymocytes to the medulla is essential for negative selection to tissue-restricted antigens PNAS, October 6, 2009; 106(40): 17129 - 17133. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Martins, T. Boehm, and C. C. Bleul Lt{beta}r Signaling Does Not Regulate Aire-Dependent Transcripts in Medullary Thymic Epithelial Cells J. Immunol., July 1, 2008; 181(1): 400 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Heikenwalder, M. Prinz, N. Zeller, K. S. Lang, T. Junt, S. Rossi, A. Tumanov, H. Schmidt, J. Priller, L. Flatz, et al. Overexpression of Lymphotoxin in T Cells Induces Fulminant Thymic Involution Am. J. Pathol., June 1, 2008; 172(6): 1555 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Seach, T. Ueno, A. L. Fletcher, T. Lowen, M. Mattesich, C. R. Engwerda, H. S. Scott, C. F. Ware, A. P. Chidgey, D. H. D. Gray, et al. The Lymphotoxin Pathway Regulates Aire-Independent Expression of Ectopic Genes and Chemokines in Thymic Stromal Cells J. Immunol., April 15, 2008; 180(8): 5384 - 5392. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |